Adverum Biotechnologies, Inc. is a leading biotechnology company based in Redwood City, CA. They are dedicated to redefining sight for life through the development of gene therapy treatments for debilitating ocular diseases. Their innovative technology utilizes a proprietary adeno-associated virus vector platform to create long-lasting therapies that can be administered in-office, eliminating the need for frequent injections and greatly improving accessibility to treatment.
With a global mission to establish gene therapy as the new standard of care for vision loss, Adverum aims to develop functional cures for highly prevalent ocular diseases, such as wet age-related macular degeneration (wet AMD). Their lead program, Ixo-vec, offers the potential to extend treatment benefit from weeks to years, providing hope for patients and caregivers seeking effective and convenient solutions to prevent blindness and restore vision.
Generated from the website